Get Relief From Obstructive Sleep Apnea - Vivos Blog

Blog

Filter

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Vivos Reports 2023 Q3 Financial Results and Operational Update

Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

Vivos Announces Collaboration in the Middle East North Africa to Support International Expansion

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference

Vivos Reports Q2 2023 Financial Results & Provides Operational Update

Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call